In fact, Baeck et al. [136] found that mNOX-E36, which inhibited CCL2 by binding, reduced the amount of intrahepatic macrophages and proinflammatory cytokines and ameliorated hepatic steatosis in methionine-choline-deficient diet mice with NASH. Here, CCL2 is linked to metabolic dysfunction-associated steatohepatitis.